BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,551,275 | +11.7% | 40,867 | +34.7% | 0.01% | +200.0% |
| Q2 2023 | $1,389,397 | +391.0% | 30,332 | +478.4% | 0.00% | -50.0% |
| Q3 2022 | $283,000 | -22.7% | 5,244 | -8.0% | 0.00% | 0.0% |
| Q2 2022 | $366,000 | -46.4% | 5,699 | -35.0% | 0.00% | -42.9% |
| Q1 2022 | $683,000 | -13.3% | 8,772 | -4.2% | 0.01% | -12.5% |
| Q4 2021 | $788,000 | +17.4% | 9,156 | +10.2% | 0.01% | -11.1% |
| Q3 2021 | $671,000 | +45.6% | 8,309 | +45.4% | 0.01% | +28.6% |
| Q2 2021 | $461,000 | -25.2% | 5,716 | -21.5% | 0.01% | -30.0% |
| Q1 2021 | $616,000 | +11.0% | 7,281 | +5.5% | 0.01% | +11.1% |
| Q4 2020 | $555,000 | -20.9% | 6,900 | -20.7% | 0.01% | -30.8% |
| Q3 2020 | $702,000 | -9.3% | 8,700 | -2.9% | 0.01% | -23.5% |
| Q2 2020 | $774,000 | +27.9% | 8,959 | +20.5% | 0.02% | -5.6% |
| Q1 2020 | $605,000 | +12.7% | 7,435 | +16.2% | 0.02% | +20.0% |
| Q4 2019 | $537,000 | +35.9% | 6,400 | +42.1% | 0.02% | +25.0% |
| Q3 2019 | $395,000 | +19.7% | 4,505 | +12.1% | 0.01% | +20.0% |
| Q2 2019 | $330,000 | +17.4% | 4,018 | +16.3% | 0.01% | -9.1% |
| Q1 2019 | $281,000 | +46.4% | 3,455 | +18.6% | 0.01% | 0.0% |
| Q4 2018 | $192,000 | – | 2,912 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |